|
Emerging Options in Reduced-Intensity Stem Cell Transplantation: Who, How, and When?
Adapted from a continuing medical education symposium presented at the 2009 BMT Tandem Meetings, on February 13, 2009 in Tampa, Florida
The speakers address these challenges and outline future directions that can potentially lead to reduced toxicity and improved long-term outcomes.
1.0 AMA PRA Category 1 Credit™
Supported by an educational grant from Otsuka America Pharmaceuticals, Inc.
|
|
ADHF Diagnosis & Risk Stratification in the Emergency Setting
W. Frank Peacock, IV, MD
Vice Chief, Emergency Medicine, Medical Director, Event Medicine, The Cleveland Clinic, Cleveland, OH
Management of AHF: Review of Contemporary Therapies and Current Guidelines
J. Douglas Kirk, MD
Director, Chest Pain Evaluation Unit Department of Emergency Medicine, University of California, Davis, Medical Center, Sacramento, CA
Future Directions in ADHF Treatment
Peter E. Carson, MD
Associate Professor of Medicine, Co-Director of Heart Failure Service, Georgetown University, Washington, DC
Live symposium supported through an educational grant from Otsuka America Pharmaceuticals, Inc.
|